ARMI COO Jennifer MacDonald, MD, will moderate a closing session on preparing New Hampshire health care providers for regenerative medicine at the 2026 NHHA/FHC Annual Meeting.
ARMI will attend TERMIS-AM 2026, the premier North American conference for tissue engineering and regenerative medicine, bringing together researchers, clinicians, industry leaders, and innovators advancing the future of regenerative therapies.
ARMI will attend the Cell & Gene Meeting on the Mesa 2026, one of the industry’s leading conferences focused on overcoming the commercialization, manufacturing, and investment challenges facing advanced therapies
ARMI will attend the 2026 Military Health System Research Symposium (MHSRS), the Department of Defense’s premier scientific meeting focused on military medical research, healthcare innovation, and warfighter readiness.
ARMI will attend the ISSCR 2026 Annual Meeting, the premier global gathering for stem cell research and regenerative medicine, to connect with scientific leaders and explore emerging advances shaping the future of the field.
ARMI Chief Operating Officer Jennifer MacDonald will participate in a panel discussion at the Cell & Gene Therapy Summit 2026, exploring the scientific, manufacturing, regulatory, and commercialization challenges involved in bringing advanced therapies to patients.
ARMI will attend BIO 2026 to connect with biotechnology leaders, explore partnership opportunities, and engage in discussions shaping the future of advanced biomanufacturing and regenerative medicine.
The ReGen Valley Community Update highlights regional progress in regenerative medicine and biomanufacturing, bringing together industry, education, workforce, and community leaders to showcase how collaboration is building the infrastructure needed to support the bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
